A ‘cure’ for haemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.
Clinical researchers at Barts Health NHS Trust and Queen Mary University of London have found that over one year on from a single treatment with a gene therapy drug, participants with haemophilia A (the most common type) are showing normal levels of the previously missing protein, and effectively curing them.
A single infusion of the gene therapy drug showed improved levels of the essential blood clotting protein Factor VIII, with 85 per cent of patients achieving normal or near-normal Factor VIII levels even many months after treatment.
The ‘transformational’ results have particular significance as the first successful gene therapy trial for the haemophilia A.
A hereditary genetic condition
There are around 2000 people with severe haemophilia A in the UK. A hereditary genetic condition dominantly affecting men, people with severe haemophilia A have virtually none of the protein factor VIII which is essential for blood to clot. It puts those affected at risk of excessive bleeding even from the slightest injury as well as causing spontaneous internal bleeding, which can be life-threatening. Recurring bleeding into joints can also lead to progressive joint damage and arthritis. The only current treatment involves multiple weekly injections to control and prevent bleeding, but there is no cure.
The trial saw patients across England injected with a copy of the missing gene, which allows their cells to produce the missing clotting factor. Following patients for up to nineteen months, tests show that eleven out of thirteen patients in the trial now have normal or near normal levels of the previously missing factor and all thirteen patients have been able to stop their previously regular treatment.
Professor John Pasi, Haemophilia Centre Director at Barts Health NHS Trust and Professor of Haemostasis and Thrombosis at Queen Mary University of London explained: “We have seen mind-blowing results which have far exceeded our expectations. When we started out we thought it would be a huge achievement to show a five per cent improvement, so to actually be seeing normal or near normal factor levels with dramatic reduction in bleeding is quite simply amazing. We really now have the potential to transform care for people with haemophilia using a single treatment for people who at the moment must inject themselves as often as every other day. It is so exciting.”
The team will now hold further tests widening participants globally to include people in the USA, Europe, Africa and South America.
Professor Pasi continued: “Incredibly exciting is the potential for a significant change in how haemophilia is treated globally. A single dose of medication that can so dramatically improve the lives of patients across the world is an amazing prospect.”
Professor Jo Martin, President, The Royal College of Pathologists said: “Pathology research is often responsible for ground-breaking developments in diagnoses and treatments that transform the lives of patients.
“What is truly remarkable about this revolutionary new gene therapy are the profound life-changing effects it offers patients with haemophilia. We would like to congratulate College fellow, Professor Pasi, and his team at Barts Health NHS Trust and Queen Mary University of London for their work in creating a simple but transformational treatment for patients.”
Jake Omer, 29 lives in Billericay and is married with two children, aged 3 years and a baby of 5 weeks. Diagnosed at two years old, he has had frequent injections of factor VIII to prevent bleeds ever since. Before he was treated with the gene therapy, Jake would wake up early before work to inject three times a week as well as injecting whenever he had an injury to stop the bleeding. As a result of of repeated bleeding Jake has arthritis in his ankles. His father is a Turk-Cypriot and as a child he and his family could never travel to visit relatives in case he needed medical care as the facilities wouldn’t have been available.
Jake said: “The gene therapy has changed my life. I now have hope for my future. It is incredible to now hope that I can play with my kids, kick a ball around and climb trees well into my kids’ teenage years and beyond. The arthritis in my ankles meant I used to worry how far I would be able to walk once I turned 40. At 23 I struggled to run 100m to catch a bus; now at 29 I’m walking two miles every day which I just couldn’t have done before having the gene therapy treatment.
“It’s really strange to not have to worry about bleeding or swellings. The first time I noticed a difference was about four months after the treatment when I dropped a weight in the gym, bashing my elbow really badly. I started to panic thinking this is going to be really bad, but after icing it that night I woke up and it looked normal. That was the moment I saw proof and knew that the gene therapy had worked.”
The Latest on: Haemophilia
- The Corporate Reputation of Pharma, Worldwide 2018-2019: The Patient Perspective - Views of 27 Patient Groups with an Interest in Bleeding Disorderson November 14, 2019 at 4:40 pm
The views of 27 patient groups specialising in bleeding disorders (94% in haemophilia). Drawn from a November 2018-February 2019 survey. Eight companies analysed in this report: Bayer - CSL Behring - ...
- Contaminated blood: Victims hit out at lower NI support paymentson November 14, 2019 at 10:36 am
The scandal resulted in people who had haemophilia being treated with blood infected with hepatitis C or HIV in the 1970s and 1980s. A public inquiry into the infected blood scandal began earlier this ...
- Hemophilia A and B Recombinant Factor Replacement Therapy Market - Uncertainty Prevailson November 14, 2019 at 7:40 am
"Global Hemophilia A and B Recombinant Factor Replacement Therapy Market by Type (, Haemophilia A & Haemophilia B), by End-Users/Application (Hospitals, Clinics & Ambulatory Surgical Centers), ...
- You Don’t Look Sick: ‘I won’t let haemophilia define me as a person’on November 10, 2019 at 12:41 am
Paul Stephens, 18, from Surrey, was diagnosed with haemophilia A when he was born. It is a rare genetic bleeding disorder, which means he lacks the factors responsible for blood clotting. It means ...
- Haemophilia Market Analysis by Recent Developments and Research 2019 to 2023on November 8, 2019 at 4:57 am
Nov 08, 2019 (Market Insight Reports via COMTEX) -- The report titled "Global Haemophilia Market, By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country ...
- Freeline presents pre-clinical data at ASH meetingon November 6, 2019 at 5:14 am
We focus on delivering dramatic efficacy for patients in areas of high unmet need. Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61 st ASH Annual ...
- Fatimid Foundation chairman calls on Balochistan CMon November 5, 2019 at 6:40 pm
QUETTA: Fatimid Foundation chairman retired Lt Gen Moinuddin Haider on Tuesday called on Balochistan Chief Minister Jam Kamal Khan Alyani to discuss provision of thalassaemia and haemophilia treatment ...
- Special treatment protocol for haemophilia patients on anvilon November 5, 2019 at 5:41 pm
THIRUVANANTHAPURAM: A special treatment protocol will be prepared for haemophilia patients in the state, said Health Minister K K Shailaja on Tuesday. Answering a submission from Leader of Opposition ...
- ‘Complete rethink’ over sport risks for people with haemophiliaon November 5, 2019 at 9:55 am
Haemophilia nurses can now encourage patients to take part in physical activity, contrary to previous advice, experts have said. Previously, health professionals had been told to warn people with ...
- “Never In Human History Had A Haemophiliac Competed At Top Level Of Combat Sports” – An Extract From Paddy Holohan’s ‘Hooligan’on November 3, 2019 at 7:35 am
Then he mentioned that when he was going through my files, there was a note that there had been a haemophilia team present at my previous back surgery. ‘Why were those guys there?’ he asked me. In the ...
via Google News and Bing News